Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRADA: Raltegravir and Atazanavir Once Daily in HIV
NCT00943540Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jul 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of raltegravir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Radboud University Medical Center. Started Jul 2009; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00943540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00943540.